Xanthelasma palpebrarum
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
21.04.2015
The ASCLEPION EFFECT: Spot on for perfect skin
With the concept „THE ASCLEPION EFFECT“ Asclepion Laser Technologies aims to communicate to the users the advatages of laser technology „Made in Germany“ and to increase the well being of […]
23.01.2021
The lower face: shaping and contouring with fillers from the Galderma portfolio*
* Lunch symposium “The lower third of the face – treatment challenges and optimal product selection (hyaluron-filler)” at the 50th Annual Meeting of the German Society of Plastic, Reconstructive and […]